Join global life science investors 

Qualified investors can attend for free. Please check qualifying T&Cs before you register



Qualified investors attend for free

Qualified investors include:

  1. Senior management or investment staff with a Fund (ETF, mutual fund, or other non- bank institution) currently invested in life sciences.
  2. Senior management or investment staff from a pension or employee benefit plan currently invested in life sciences.
  3. Senior management at a family office currently or previously invested in life sciences.
  4. Senior leadership or management with a venture or private equity firm managing assets of $25 million or more.
  5. Senior management at an angel investor fund (or group) currently or previously invested in life sciences. Not individual Angels.
  6. Senior management at a charitable or not-for-profit organization with a fund of $5 million or more currently invested in the life sciences.
  7. Research Analyst for a fund currently invested in UK/EU/US/Asian life science companies.

An investor who receives complimentary registration is expected to participate in the One- on-One Partnering, with at least five meetings secured through the system with life science companies.

Attendees who do not qualify for complimentary registration include:

  1. Executives who invest personal, disposable income, who's salaried occupation is not that of a full time investor (ie. not individual Angels)
  2. Firms who offer advisory or consulting services of any nature.
  3. Service providers/consultants to the biotech industry.
  4. Biotech/ life sciences company employee or product suppliers to the biotech industry including CRO’s and CMO’s.
  5. Firms that provide services and/or charge a fee to biotech companies in exchange for research/media/investor relations coverage.
  6. Retail/individual investors.
  7. Investment and merchant bankers.
  8. Real estate development professionals.
  9. Members of economic development organisations.
  10. Firms who have a service providing component to their fund’s business model will be evaluated on a case by case basis. If this fund’s information is NOT located in any mainstream database (Ipreo, FactSet), LSX may ask for references for investor qualification.

LSX reserves the right, in its sole discretion, to make the determination of the proper classification of an investor or registrant. Depending on this classification, registration fees may be required.

LSX reserves the right to publish materials and restrict conference and/or partnering system access consistent with these determinations.

If you have any questions please contact  

Just a snapshot of our past investors

3B Future Health Ventures Logo
4bio Capital Logo
ALSA Ventures Logo
Andera Partners Logo
Arrowfield Capital Logo
Bain Capital Life Sciences Logo
Biomark Capital Logo
Breed Reply Logo
Broadview Ventures Logo
Cambridge Innovation Capital Logo
Clavis Capital Logo
CTI Life Sciences Logo
Debiopharm Innovation Fund Logo
Deepbridge Capital 300x150
Digital Networks plc 300x
Droege Group Logo
Eir Ventures Logo
Endeavour Vision Logo
European Investment Fund Logo
Fresenius Medical Care Ventures 300x150
Green Sky Capital 300x
HCR Partners Logo
Heran Partners Logo
Human Alfa Logo
imec xpand Logo
Industrifonden Logo
Inveready Logo
IPF Partners Logo
Karista Logo
Kreos Capital Logo
LifeArc Ventures Logo
Lightstone Ventures Logo
M Ventures Logo
MedTecX 300x150
Mercia Asset Management 300x150
MIRA Life Science Ventures 300x
New Science Fund Logo
Norgine Ventures Logo
Octopus Ventures Logo
Omnes Capital Logo
OrbiMed Advisors Logo
Panacea Venture Logo
Parkwalk Advisors Logo
Peppermint Venture Partners Logo
Prevail Partners Logo
Rhia Ventures Logo
RTW Investments Logo
Sanara Ventures Logo
Sarsia Seed Logo
Seventure Logo
SR One Logo
Touchdown Ventures Logo
TVM Capital Logo
Valiance 300x
Vespucci Partners Logo
Vickers Venture Partners Logo
Voima Ventures Logo
Wellington Partners Logo